Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

Details for Australian Patent Application No. 2006250009 (hide)

Owner Theravance, Inc.

Inventors Marquess, Daniel; Long, Daniel D.; Dalziel, Sean M.; Jiang, Lan; McKinnell, Robert Murray; Choi, Seok-Ki; Fatheree, Paul R.; Gendron, Roland; Phizackerley, Kirsten M.

Agent Davies Collison Cave

Pub. Number AU-B-2006250009

PCT Pub. Number WO2006/127815

Priority 60/748,415 08.12.05 US; 60/684,478 25.05.05 US; 60/684,466 25.05.05 US

Filing date 24 May 2006

Wipo publication date 30 November 2006

Acceptance publication date 8 March 2012

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4545 (2006.01)

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/127815 Priority application(s): WO2006/127815

8 March 2012 Application Accepted

  Published as AU-B-2006250009

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006250020-Distributed analysis system

2006250004-Bacterial cellulose-containing formulations and method of producing effective bacterial cellulose-containing formulations